pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jun 30·1 min read
save

Trump administration downplays alcohol risks, hindering efforts to curb drinking-related harms

Jun 30, 2026·read at STAT ↗RegulatoryNegative

A STAT investigation reported that the Trump administration has downplayed the health risks of alcohol and has taken steps that obstruct research into drinking-related harms.

Although alcohol is responsible for more deaths in the United States each year than infectious diseases and opioids combined, the Make America Healthy Again (MAHA) movement and its leader Robert F. Kennedy Jr. have largely sidestepped the issue.

The report says the administration’s approach includes minimizing warnings and actively derailing efforts to better understand and prevent the harms caused by excessive drinking.

The article contrasts this lax stance with recent scrutiny of other health concerns such as seed oils, sugary drinks, pesticides, pharmaceuticals and vaccines, highlighting alcohol as a missed target.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Even with MAHA, Trump administration has gone soft on alcohol”

read at STAT ↗
699 words · retrieved Jul 1
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
ELI LILLY COEli Lilly and CoLILLYNOVONovo Nordisk Inc
drugs
Obesity
topics
Vaccines2Gene Therapy (AAV)Major DepressionObesity

related stories

  • Sep 23Novo’s turnaround plan, weight loss wins, Ultragenyx’s Sanfilippo approval, IPO blitzBioSpace
  • Jun 30Republican Tom Kean Jr. reveals depression diagnosis after his four-month absence from CongressSTAT
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • Apr 24Lilly tumbles on Foundayo’s shaky week; FDA to issue vouchers for psychedelicsBioPharma Dive
  • Dec 22Fierce Biotech Fundraising Tracker '26: Matchpoint makes $150M; KymaThera corrals $80MFierce Biotech